Cyclerion Therapeutics
CYCN
CYCN
73 hedge funds and large institutions have $140M invested in Cyclerion Therapeutics in 2020 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 19 increasing their positions, 25 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
24% less repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 25
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
73
Holding in Top 10
–
Calls
$76K
Puts
–
Top Buyers
| 1 | +$30.4M | |
| 2 | +$3.63M | |
| 3 | +$588K | |
| 4 |
Charles Schwab
San Francisco,
California
|
+$363K |
| 5 |
Morgan Stanley
New York
|
+$330K |
Top Sellers
| 1 | -$1.46M | |
| 2 | -$691K | |
| 3 | -$502K | |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$466K |
| 5 |
State Street
Boston,
Massachusetts
|
-$371K |